<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03134898</url>
  </required_header>
  <id_info>
    <org_study_id>OSIRIS</org_study_id>
    <nct_id>NCT03134898</nct_id>
  </id_info>
  <brief_title>Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension</brief_title>
  <official_title>Longitudinal Study to Identify Predictive Factors of Post-thrombotic Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Delos Clinical</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Delos Clinical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current data on the incidence of pulmonary hypertension (PH) are very variable, depending
      on the different studies designs. There are no data on the prognostic of PH in patients with
      asymptomatic pulmonary thromboembolisms (PT), neither paucisymptomatic PH, in which without a
      prospective follow-up would be underdiagnosed. We thought that the prognosis of both clinical
      forms (PT with or without symptoms) would be similar.

      The objective of this study is know the real incidence of pulmonary hypertension (PH) post
      symptomatic and asymptomatic pulmonary thromboembolic (PT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale

      Pulmonary hypertension (PH) post pulmonary thromboembolisms is a serious and complex disease,
      is one major cause of pulmonary hypertension (1). It is the most feared late complication of
      pulmonary thromboembolism (PT) characterized by the organization of thrombotic material
      within the pulmonary arteries (2). Although a purely mechanical theory is too simplistic in
      view of the lack of correlation between the proportion of obliterated pulmonary arteries and
      the numbers of PH.

      Acute, symptomatic, or asymptomatic PT may be the initial event, but disease progression
      would result from progressive vascular remodeling of small vessels. It is possible that
      unresolved pulmonary arterial thrombosis is a decisive factor for vascular endothelial cells
      to initiate their mesenchymal transition (3).

      On the other hand, Pulmonary hypertension post pulmonary thromboembolisms is the only
      subclass of pulmonary hypertension that has a curative surgical treatment (4). The diagnosis
      of this situation should be detected as soon as possible to optimize the results of surgical
      and pharmacological treatment. Surgical indication should be established as early as possible
      to avoid progression (5).

      Hypothesis

      The current data on the incidence of PH are very variable, depending on the different studies
      designs. There are no data on the prognostic of PH in patients with asymptomatic PT, neither
      paucisymptomatic PH, in which without a prospective follow-up would be underdiagnosed. We
      thought that the prognosis of both clinical forms (PT with or without symptoms) would be
      similar. Also we thought and that there are forms of paucisymptomatic PH whose diagnosis and
      treatment would benefit from a prospective follow-up.

      Objectives

      Main objective

      To know the incidence of pulmonary hypertension (PH) post symptomatic and asymptomatic
      pulmonary thromboembolic (PT).

      The secondary objectives of the study are:

        -  To defined clinical subtypes of PT with a predictive value of diagnosis of PH in two
           years.

        -  To Measure biomarkers described that may be related to the diagnosis of PH or the
           disease progression.

        -  Use of genetic, proteomic, RNA transcription, cytometric and cellular and metabolic
           identification assays to aid in the search for new genetic factors and / or PH
           biomarkers.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 24, 2013</start_date>
  <completion_date type="Anticipated">December 31, 2017</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Pulmonary hypertension</measure>
    <time_frame>2 years</time_frame>
    <description>Diagnosis on pulmonary hypertension after pulmonary thromboembolism</description>
  </primary_outcome>
  <enrollment type="Anticipated">1025</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <condition>Pulmonary Thromboembolisms</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with diagnosis of incidental or symptomatic pulmonary thromboembolisms
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18 years or older and able to provide informed consent

          -  Diagnosis of pulmonary thromboembolisms confirmed by

          -  Computed Tomography Angiography (CTA) if there are a partial transluminal defect
             surrounded by contrast or a complete occlusion of pulmonary artery.

          -  Pulmonary ventilation/perfusion scan.- Patients with high risk based on PIOPED study
             criteria or in patients with deep venous thrombosis confirmed by echography and
             positron emission tomography (PET) scan not concluding.

        Exclusion Criteria:

          -  Any contraindication to the performance of the pulmonary hypertension diagnostic tests

          -  Any circumstance, to investigator criteria, to impede the patient follow up

          -  Life expectancy lower than 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Remedios Otero Candelera</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario Virgen del Rocío IBIS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emilio Cabrera</last_name>
    <email>emiliogcabrera@delosclinical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital U. Central. de Asturias</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Bedate Díaz</last_name>
    </contact>
    <investigator>
      <last_name>Pedro Bedate Díaz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital M. de Badalona</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Carlos Sahuquillo Llamas</last_name>
    </contact>
    <investigator>
      <last_name>Juan Carlos Sahuquillo Llamas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. German Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel Monreal Bosch</last_name>
    </contact>
    <investigator>
      <last_name>Manuel Monreal Bosch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital G. de Cataluña</name>
      <address>
        <city>Sant Cugat del Valles</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fátima del Molino Sanz</last_name>
    </contact>
    <investigator>
      <last_name>Fátima del Molino Sanz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Viladecans</name>
      <address>
        <city>Viladecans</city>
        <state>Barcelona</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariano Valdés Oliveras</last_name>
    </contact>
    <investigator>
      <last_name>Mariano Valdés Oliveras</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramón Agüero Balbín</last_name>
    </contact>
    <investigator>
      <last_name>Ramón Agüero Balbín</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sierrallana</name>
      <address>
        <city>Torrelavega</city>
        <state>Cantabria</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernad Sierra Valle</last_name>
    </contact>
    <investigator>
      <last_name>Bernad Sierra Valle</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Cruces</name>
      <address>
        <city>Bilbao</city>
        <state>Guipuzcua</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando Uresandi Romero</last_name>
    </contact>
    <investigator>
      <last_name>Fernando Uresandi Romero</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital San Pedro</name>
      <address>
        <city>Logrono</city>
        <state>La Rioja</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercedes Alcalde Manero</last_name>
    </contact>
    <investigator>
      <last_name>Mercedes Alcalde Manero</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Barrón Medrano</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. Fundación Alcorcón</name>
      <address>
        <city>Alcorcón</city>
        <state>Madrid</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercedes Izquierdo Patrón</last_name>
    </contact>
    <investigator>
      <last_name>Mercedes Izquierdo Patrón</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. de Getafe</name>
      <address>
        <city>Getafe</city>
        <state>Madrid</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María Antonia Juretschke Moragues</last_name>
    </contact>
    <investigator>
      <last_name>María Antonia Juretschke Moragues</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen del Camino</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gregorio Tiberio López</last_name>
    </contact>
    <investigator>
      <last_name>Gregorio Tiberio López</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen del Rocío</name>
      <address>
        <city>Seville</city>
        <state>Sevilla</state>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Remedios Otero Candelera</last_name>
    </contact>
    <investigator>
      <last_name>Remedios Otero Candelera</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Galdakao-Usansolo</name>
      <address>
        <city>Galdacano</city>
        <state>Vizcaya</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aitor Ballaz Quincoces</last_name>
    </contact>
    <investigator>
      <last_name>Aitor Ballaz Quincoces</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital de Araba</name>
      <address>
        <city>Alava</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Luis Lobo Beristaín</last_name>
    </contact>
    <investigator>
      <last_name>José Luis Lobo Beristaín</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diego Agustín Rodriguez</last_name>
    </contact>
    <investigator>
      <last_name>Diego Agustín Rodriguez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. de Girona Doctor Josep Trueta</name>
      <address>
        <city>Gerona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fernando García Bragado</last_name>
    </contact>
    <investigator>
      <last_name>Fernando García Bragado</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignacio Casado Moreno</last_name>
    </contact>
    <investigator>
      <last_name>Ignacio Casado Moreno</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María del Carmen Fernández Capitán</last_name>
    </contact>
    <investigator>
      <last_name>María del Carmen Fernández Capitán</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital U. Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Jiménez Castro</last_name>
    </contact>
    <investigator>
      <last_name>David Jiménez Castro</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital San Juan de Dios</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Consolación Rodríguez Matute</last_name>
    </contact>
    <investigator>
      <last_name>Consolación Rodríguez Matute</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital C. U. de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agueda Herrero López</last_name>
    </contact>
    <investigator>
      <last_name>Agueda Herrero López</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital C. U. Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Conget López</last_name>
    </contact>
    <investigator>
      <last_name>Francisco Conget López</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Tueller C, Stricker H, Soccal P, Tamm M, Aubert JD, Maggiorini M, Zwahlen M, Nicod L; Swiss Society for Pulmonary Hypertension. Epidemiology of pulmonary hypertension: new data from the Swiss registry. Swiss Med Wkly. 2008 Jun 28;138(25-26):379-84. doi: 2008/25/smw-11915.</citation>
    <PMID>18587690</PMID>
  </reference>
  <reference>
    <citation>Lang IM. Chronic thromboembolic pulmonary hypertension--not so rare after all. N Engl J Med. 2004 May 27;350(22):2236-8.</citation>
    <PMID>15163772</PMID>
  </reference>
  <reference>
    <citation>Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev. 2010 Mar;19(115):59-63. doi: 10.1183/09059180.00007309. Review.</citation>
    <PMID>20956167</PMID>
  </reference>
  <reference>
    <citation>Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Hodgkins D, Goldsmith K, Hughes RJ, Sheares K, Tsui SS, Armstrong IJ, Torpy C, Crackett R, Carlin CM, Das C, Coghlan JG, Pepke-Zaba J. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008 May 15;177(10):1122-7. doi: 10.1164/rccm.200712-1841OC. Epub 2008 Feb 21.</citation>
    <PMID>18292468</PMID>
  </reference>
  <reference>
    <citation>Galiè N, Kim NH. Pulmonary microvascular disease in chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006 Sep;3(7):571-6. Review.</citation>
    <PMID>16963536</PMID>
  </reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2017</study_first_submitted>
  <study_first_submitted_qc>April 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2017</study_first_posted>
  <last_update_submitted>April 26, 2017</last_update_submitted>
  <last_update_submitted_qc>April 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospitales Universitarios Virgen del Rocío</investigator_affiliation>
    <investigator_full_name>Remedios Otero Candelera</investigator_full_name>
    <investigator_title>MD Ph D</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

